|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
|
US6964946B1
(en)
*
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6727280B2
(en)
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9715759D0
(en)
*
|
1997-07-26 |
1997-10-01 |
Danbiosyst Uk |
New emulsion formulations
|
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
|
EP1135150B1
(en)
*
|
1998-12-11 |
2012-10-17 |
Tris Pharma, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
|
US7026290B1
(en)
|
1998-12-30 |
2006-04-11 |
Dexcel Ltd. |
Dispersible concentrate for the delivery of cyclosprin
|
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
|
AU4053700A
(en)
*
|
1999-04-02 |
2000-10-23 |
Washington State University Research Foundation |
Enhanced tissue and subcellular delivery of vitamin e compounds
|
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
HUP0203903A3
(en)
*
|
1999-04-13 |
2004-09-28 |
Leo Pharm Prod Ltd |
Solubilized pharmaceutical composition for parenteral administration and its use
|
|
JP2003500368A
(ja)
*
|
1999-05-24 |
2003-01-07 |
ソーナス ファーマシューティカルス，インコーポレイテッド |
溶解度が不十分な薬剤のためのエマルジョンビヒクル
|
|
KR100754352B1
(ko)
*
|
1999-05-24 |
2007-08-31 |
소너스파머슈티칼즈인코포레이티드 |
난용성 약물용 에멀젼 부형제의 제조방법
|
|
EP1479382A1
(en)
*
|
1999-06-18 |
2004-11-24 |
IVAX Research, Inc. |
Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same
|
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
KR20020059415A
(ko)
*
|
1999-09-27 |
2002-07-12 |
스티븐 씨. 큐웨이 |
토콜-가용성 치료요법제
|
|
US6828346B2
(en)
*
|
1999-10-25 |
2004-12-07 |
Supergen, Inc. |
Methods for administration of paclitaxel
|
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
AU2001225432A1
(en)
*
|
2000-01-20 |
2001-07-31 |
Supratek Pharma, Inc. |
Novel podophyllotoxin compositions
|
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
|
US8618085B2
(en)
*
|
2000-04-28 |
2013-12-31 |
Koasn Biosciences Incorporated |
Therapeutic formulations of desoxyepothilones
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
GB0016876D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Novel formulation
|
|
CA2410683A1
(en)
*
|
2000-07-24 |
2002-01-31 |
Pharmacia & Upjohn Company |
Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
WO2002026208A2
(en)
*
|
2000-09-27 |
2002-04-04 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
CA2426885C
(en)
*
|
2000-11-14 |
2010-06-29 |
Vital Health Sciences Pty Ltd |
Complexes of phosphate derivatives
|
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
|
MXPA03004546A
(es)
*
|
2000-11-22 |
2003-09-10 |
Rxkinetix Inc |
Tratamiento de mucositis.
|
|
US6919370B2
(en)
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
|
EP1345589B1
(en)
*
|
2000-11-29 |
2007-06-27 |
Lyotropic Therapeutics, Inc. |
Solvent systems for pharmaceutical agents
|
|
ATE414511T1
(de)
*
|
2000-12-05 |
2008-12-15 |
Los Angeles Childrens Hospital |
Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
|
|
IN188917B
(enExample)
*
|
2000-12-07 |
2002-11-23 |
Bharat Surums & Vaccines Ltd |
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
US8008345B2
(en)
|
2001-07-27 |
2011-08-30 |
Vital Health Sciences Pty. Ltd. |
Dermal therapy using phosphate derivatives of electron transfer agents
|
|
AUPR684801A0
(en)
*
|
2001-08-06 |
2001-08-30 |
Vital Health Sciences Pty Ltd |
Supplement therapy
|
|
US20030099674A1
(en)
*
|
2001-08-11 |
2003-05-29 |
Chen Andrew X. |
Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
WO2003026611A2
(en)
|
2001-09-26 |
2003-04-03 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
|
US20040092428A1
(en)
*
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
|
JP2005515996A
(ja)
*
|
2001-12-03 |
2005-06-02 |
ノバセア インコーポレイティッド |
活性型ビタミンｄ化合物を含む薬学的組成物
|
|
US20060078618A1
(en)
*
|
2001-12-11 |
2006-04-13 |
Constantinides Panayiotis P |
Lipid particles and suspensions and uses thereof
|
|
EP1460995B1
(en)
*
|
2001-12-13 |
2010-11-10 |
Vital Health Sciences Pty Ltd. |
Transdermal transport of compounds
|
|
CA2475092C
(en)
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
|
US6683194B2
(en)
*
|
2002-02-05 |
2004-01-27 |
Sonus Pharmaceuticals, Inc. |
Tocopherol derivatives
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
ATE494010T1
(de)
*
|
2002-02-27 |
2011-01-15 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
EP1340497A1
(en)
*
|
2002-03-01 |
2003-09-03 |
Novagali Sas |
Self emulsifying drug delivery systems for poorly soluble drugs
|
|
IL163808A0
(en)
*
|
2002-03-01 |
2005-12-18 |
Yissum Res Dev Co |
Self emulsifying drug delivery systems for poorly soluble drugs
|
|
US20080004332A1
(en)
*
|
2002-03-07 |
2008-01-03 |
Alkon Daniel L |
Methods for alzheimer's disease treatment and cognitive enhancement
|
|
US6825229B2
(en)
|
2002-03-07 |
2004-11-30 |
Blanchette Rockefeller Neurosciences Institute |
Methods for Alzheimer's Disease treatment and cognitive enhancement
|
|
US20050065205A1
(en)
*
|
2002-03-07 |
2005-03-24 |
Daniel Alkon |
Methods for Alzheimer's disease treatment and cognitive enhance
|
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
EP1509256B1
(en)
|
2002-05-24 |
2009-07-22 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
WO2004011000A1
(en)
*
|
2002-07-30 |
2004-02-05 |
Wyeth |
Parenteral formulations containing a rapamycin hydroxyester
|
|
AU2002950713A0
(en)
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
KR100996996B1
(ko)
|
2002-11-07 |
2010-11-25 |
코산 바이오사이언시즈, 인코포레이티드 |
트랜스-9,10-디히드로에포틸론 ｃ 및 ｄ, 그것의 유사체 및 그것의 제조 방법
|
|
KR100507771B1
(ko)
*
|
2002-11-08 |
2005-08-17 |
한미약품 주식회사 |
난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
|
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
EP2359859A1
(en)
|
2002-12-09 |
2011-08-24 |
Abraxis BioScience, LLC |
Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
|
|
US20040115287A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Lipocine, Inc. |
Hydrophobic active agent compositions and methods
|
|
KR100502821B1
(ko)
|
2002-12-26 |
2005-07-22 |
이호영 |
구리산화물 또는 구리 나노와이어로 이루어진 전자방출팁의 저온 형성 방법 및 이 방법에 의해 제조된 전자방출팁을 포함하는 디스플레이 장치 또는 광원
|
|
AU2004212944B2
(en)
*
|
2003-02-14 |
2008-08-21 |
Children's Hospital & Research Center At Oakland |
Lipophilic drug delivery vehicle and methods of use thereof
|
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
US20060251685A1
(en)
*
|
2003-03-18 |
2006-11-09 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
|
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
|
WO2004091506A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Ivax Research, Inc. |
Taxane-based compositions and methods of use
|
|
US7485671B2
(en)
*
|
2003-05-16 |
2009-02-03 |
Velocys, Inc. |
Process for forming an emulsion using microchannel process technology
|
|
CA2526965C
(en)
*
|
2003-05-16 |
2011-10-11 |
Velocys Inc. |
Process for forming an emulsion using microchannel process technology
|
|
US7691838B2
(en)
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
EP1498120A1
(en)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Semi-solid formulations for the oral administration of taxoids
|
|
EP1510206A1
(en)
*
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
|
DE602004014624D1
(de)
*
|
2003-08-29 |
2008-08-07 |
Yissum Res Dev Co |
Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
|
|
US20050107465A1
(en)
*
|
2003-10-01 |
2005-05-19 |
Papas Andreas M. |
Composition for treating inflammatory bowel disease
|
|
US20050074446A1
(en)
*
|
2003-10-01 |
2005-04-07 |
Papas Andreas M. |
Gamma-tocopherol treatment for cystic fibrosis
|
|
US7311901B2
(en)
*
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
|
WO2005035606A1
(en)
|
2003-10-10 |
2005-04-21 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
|
CN100471886C
(zh)
*
|
2003-10-10 |
2009-03-25 |
株式会社三养社 |
两亲嵌段共聚物以及包含它的用于给药的聚合组合物
|
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
US20080045559A1
(en)
*
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
DE602004027936D1
(de)
*
|
2003-10-29 |
2010-08-12 |
Sonus Pharmaceutical Inc |
Tocopherolmodifizierte therapeutische arzneimittelverbindung
|
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
|
TWI350183B
(en)
*
|
2003-12-31 |
2011-10-11 |
Ind Tech Res Inst |
A liposome and a preparation method
|
|
US20050158329A1
(en)
*
|
2004-01-21 |
2005-07-21 |
Ghosh Swapan K. |
Novel phytol derived immunoadjuvants and their use in vaccine formulations
|
|
WO2005084678A1
(en)
*
|
2004-03-03 |
2005-09-15 |
Vital Health Sciences Pty Ltd |
Alkaloid formulations
|
|
US20050209315A1
(en)
*
|
2004-03-20 |
2005-09-22 |
Papas Andreas M |
Bioavailable nutritional supplement and method of treatment of malabsorption
|
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
|
US20050220866A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Dr. Reddy's Laboratories Limited |
Novel capsule formulations of etoposide for oral use
|
|
US20050226932A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Samyang Corporation |
Pharmaceutical formulations for itraconazole
|
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
|
WO2005112977A2
(en)
*
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
TW201206425A
(en)
|
2004-05-18 |
2012-02-16 |
Brni Neurosciences Inst |
Treatment of depressive disorders
|
|
KR100582604B1
(ko)
|
2004-06-16 |
2006-05-23 |
보람제약주식회사 |
항산화제를 포함한 이부프로펜 및 덱시부프로펜의마이크로 에멀젼과 이를 이용한 투명 액제 및 투명연질캡슐 제제
|
|
WO2006015120A2
(en)
*
|
2004-07-28 |
2006-02-09 |
Sd Pharmaceuticals, Inc. |
Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
|
|
EP1778289B1
(en)
*
|
2004-08-03 |
2011-01-12 |
Vital Health Sciences Pty Ltd. |
Carrier for enteral administration
|
|
KR100623013B1
(ko)
*
|
2004-09-04 |
2006-09-19 |
김영대 |
나노에멀션, 그의 용도 및 제조방법
|
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
US20060165769A1
(en)
*
|
2004-09-30 |
2006-07-27 |
Hyatt John A |
Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
|
|
JP5643474B2
(ja)
|
2004-10-01 |
2014-12-17 |
ヴェロシス，インク． |
マイクロチャネルプロセス技術を用いる多相混合プロセス
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
WO2006047579A2
(en)
*
|
2004-10-26 |
2006-05-04 |
Yasoo Health, Inc. |
Vitamin e tpgs fluid concentrate comprising a low percentage of water
|
|
US20060120213A1
(en)
*
|
2004-11-17 |
2006-06-08 |
Tonkovich Anna L |
Emulsion process using microchannel process technology
|
|
GT200500310A
(es)
*
|
2004-11-19 |
2006-06-19 |
|
Compuestos organicos
|
|
US20060147518A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Pierre Fabre Medicament |
Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
|
|
JP4877899B2
(ja)
*
|
2005-01-25 |
2012-02-15 |
学校法人近畿大学 |
薬物徐放出性球状微粒子及びその製造方法
|
|
US20090239827A1
(en)
*
|
2005-03-03 |
2009-09-24 |
Esra Ogru |
Compounds having lipid lowering properties
|
|
US20060222716A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Joseph Schwarz |
Colloidal solid lipid vehicle for pharmaceutical use
|
|
AU2006235538A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
|
US20060240051A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Singleton Andy H |
Eutectic blends containing a water soluble vitamin derivative
|
|
EP1874296A4
(en)
|
2005-04-29 |
2010-06-30 |
Kosan Biosciences Inc |
METHOD FOR THE TREATMENT OF SEVERAL MYELOMES USING 17-AAG OR 17-AG OR PRODRUGS OR ALL
|
|
JP4866349B2
(ja)
*
|
2005-06-13 |
2012-02-01 |
大日本住友製薬株式会社 |
可溶化型製剤
|
|
EP2548581A3
(en)
*
|
2005-06-17 |
2013-02-20 |
Vital Health Sciences Pty Ltd. |
A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
|
EP1915145A1
(en)
|
2005-07-29 |
2008-04-30 |
Blanchette Rockefeller Neurosciences Institute |
Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
|
|
JP2009505976A
(ja)
*
|
2005-08-12 |
2009-02-12 |
アストラゼネカ・アクチエボラーグ |
方法
|
|
ATE538139T1
(de)
*
|
2005-08-30 |
2012-01-15 |
Lanxess Deutschland Gmbh |
Verwendung von katalysatoren für den metatheseabbau von nitrilkautschuk
|
|
WO2007035311A2
(en)
*
|
2005-09-16 |
2007-03-29 |
University Of Massachusetts Lowell |
Anti-oxidant synergy formulation nanoemulsions to treat cancer
|
|
EP1959926A1
(en)
*
|
2005-10-25 |
2008-08-27 |
Abbott Laboratories |
Formulation comprising a drug of low water solubility and method of use thereof
|
|
US20070104778A1
(en)
*
|
2005-11-07 |
2007-05-10 |
Hongxia Zeng |
Controlled-release emulsion compositions
|
|
EP1959966B1
(en)
|
2005-11-28 |
2020-06-03 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone formulations and methods for the making and use thereof
|
|
WO2007064755A2
(en)
*
|
2005-11-30 |
2007-06-07 |
Endo Pharmaceuticals Inc. |
Treatment of xerostomia with a sulfur-containing antioxidant
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
JP2009520040A
(ja)
|
2005-12-19 |
2009-05-21 |
ファーマイン コーポレーション |
治療薬の送達のための疎水性コアの担体組成物、及び同担体組成物の作製法及び使用法
|
|
CN101011355B
(zh)
|
2006-02-01 |
2013-01-02 |
陈献 |
经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
|
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
KR101433962B1
(ko)
*
|
2006-03-10 |
2014-08-25 |
라보스위스 아게 |
물질의 용해, 분산 및 안정을 위한 방법, 상기 방법에 따라제조된 제품 및 상기 제품의 이용
|
|
EP2024078A2
(en)
|
2006-04-20 |
2009-02-18 |
Velocys, Inc. |
Process for treating and/or forming a non-newtonian fluid using microchannel process technology
|
|
US8112292B2
(en)
|
2006-04-21 |
2012-02-07 |
Medtronic Navigation, Inc. |
Method and apparatus for optimizing a therapy
|
|
KR100917809B1
(ko)
|
2006-05-22 |
2009-09-18 |
에스케이케미칼주식회사 |
우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
|
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
|
PT2201840E
(pt)
|
2006-09-22 |
2012-02-14 |
Pharmacyclics Inc |
Inibidores da tirosina quinase de bruton
|
|
US8660635B2
(en)
|
2006-09-29 |
2014-02-25 |
Medtronic, Inc. |
Method and apparatus for optimizing a computer assisted surgical procedure
|
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
|
EP2322235A1
(en)
*
|
2006-11-20 |
2011-05-18 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
|
US20080175887A1
(en)
*
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
|
EP2101735A2
(en)
|
2006-11-28 |
2009-09-23 |
Marinus Pharmaceuticals, Inc. |
Nanoparticulate formulations and methods for the making and use thereof
|
|
BRPI0719756A2
(pt)
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Nanopartículas de entidades anfifílicas
|
|
WO2008088037A1
(ja)
*
|
2007-01-18 |
2008-07-24 |
National University Corporation Chiba University |
微粒子製剤
|
|
EP3332797A3
(en)
*
|
2007-02-09 |
2018-08-01 |
Blanchette Rockefeller Neurosciences Institute |
Therapeutic effects of bryostatins, bryologs and other related substances on head trauma-induced memory impairment and brain injury
|
|
WO2008097165A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Astrazeneca Ab |
Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
|
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术（石家庄）有限公司 |
以多西他赛为主组分的新的分散体系
|
|
WO2008106571A2
(en)
*
|
2007-02-28 |
2008-09-04 |
Abbott Laboratories |
Sustained release parenteral formulations of buprenorphine
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
AU2008269179A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Scidose Llc |
Solubilized formulation of docetaxel without Tween 80
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
CA2699157A1
(en)
|
2007-09-10 |
2009-03-19 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
ES2667945T3
(es)
*
|
2007-10-08 |
2018-05-16 |
Aurinia Pharmaceuticals Inc. |
Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
|
|
US20090130198A1
(en)
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
|
EP2231144B1
(en)
*
|
2007-12-24 |
2014-07-02 |
Sun Pharma Advanced Research Company Limited |
Nanodispersion
|
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
CN101519404B
(zh)
|
2008-02-29 |
2016-01-20 |
唐莉 |
15环噻酮衍生物及其制备方法与应用
|
|
BRPI0909185A2
(pt)
|
2008-03-20 |
2015-08-25 |
Virun Inc |
Derivado de vitamina e e seus usos
|
|
DE102008015366A1
(de)
*
|
2008-03-20 |
2009-09-24 |
Merck Patent Gmbh |
Lyophilisierte Nanoemulsion
|
|
WO2009117152A1
(en)
|
2008-03-20 |
2009-09-24 |
Virun, Inc. |
Emulsions including a peg-derivative of tocopherol
|
|
CN107088227A
(zh)
*
|
2008-03-28 |
2017-08-25 |
粒子科学有限公司 |
用于使治疗剂增溶的药物溶液和方法
|
|
US8420110B2
(en)
*
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
|
US8603531B2
(en)
|
2008-06-02 |
2013-12-10 |
Cedars-Sinai Medical Center |
Nanometer-sized prodrugs of NSAIDs
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
WO2010009075A1
(en)
*
|
2008-07-14 |
2010-01-21 |
The University Of North Carolina At Chapel Hill |
Methods and compositions comprising crystalline nanoparticles of hydrophobic compounds
|
|
FR2933871B1
(fr)
*
|
2008-07-18 |
2012-12-14 |
Yvery |
Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
|
|
EP2321303B1
(en)
|
2008-08-27 |
2019-11-27 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2010024898A2
(en)
|
2008-08-29 |
2010-03-04 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
|
CA2737607A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Richard Anthony Gibbs |
Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
|
|
US9676744B2
(en)
|
2008-09-19 |
2017-06-13 |
Purdue Research Foundation |
Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
|
|
US8165658B2
(en)
*
|
2008-09-26 |
2012-04-24 |
Medtronic, Inc. |
Method and apparatus for positioning a guide relative to a base
|
|
US20140105822A1
(en)
*
|
2008-11-24 |
2014-04-17 |
Cedars-Sinai Medical Center |
Nanospheres comprising tocopherol, an amphiphilic spacer and a therapeutic or imaging agent
|
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
JP5339980B2
(ja)
*
|
2009-03-23 |
2013-11-13 |
富士フイルム株式会社 |
分散組成物及び分散組成物の製造方法
|
|
WO2010144194A1
(en)
*
|
2009-06-09 |
2010-12-16 |
Lux Biosciences, Inc. |
Topical drug delivery systems for ophthalmic use
|
|
CA2765541A1
(en)
|
2009-06-19 |
2010-12-23 |
Sun Pharma Advanced Research Company Ltd. |
Nanodispersion of a drug and process for its preparation
|
|
EP2485768A1
(en)
|
2009-10-07 |
2012-08-15 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
CN102101863B
(zh)
|
2009-12-17 |
2014-10-15 |
唐莉 |
新型环氧噻酮化合物及其制备方法和用途
|
|
US20110166214A1
(en)
|
2010-01-07 |
2011-07-07 |
Innopharma, Llc |
Methods and compositions for delivery of taxanes in stable oil-in-water emulsions
|
|
AU2011213557B2
(en)
|
2010-02-05 |
2015-05-07 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前－乳劑調配物及其製造與使用之方法
|
|
CA2792330C
(en)
*
|
2010-03-23 |
2017-01-03 |
Virun, Inc |
Nanoemulsion including a peg-derivative of vitamin e and a sucrose fatty acid ester
|
|
SI2552199T1
(sl)
*
|
2010-03-26 |
2015-10-30 |
Onconova Therapeutics, Inc. |
Izboljšana stabilna vodna formulacija (e)-4-karboksistiril-4-klorobenzil sulfona
|
|
US8652511B2
(en)
|
2010-03-30 |
2014-02-18 |
Phosphagenics Limited |
Transdermal delivery patch
|
|
US20130030237A1
(en)
|
2010-04-15 |
2013-01-31 |
Charles Theuer |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
CA2797533A1
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
PT2563776T
(pt)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Compostos que modulam o cálcio intracelular
|
|
MX341082B
(es)
|
2010-05-03 |
2016-08-08 |
Teikoku Pharma Usa Inc |
Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas.
|
|
EP2568999B1
(en)
|
2010-05-11 |
2018-07-11 |
Mallinckrodt Ard Ip Limited |
Acth for treatment of amyotrophic lateral sclerosis
|
|
US20130172333A1
(en)
*
|
2010-05-20 |
2013-07-04 |
Synta Pharmaceuticals Corp. |
Formulation and dosing of hsp90 inhibitory compounds
|
|
EA201890869A3
(ru)
|
2010-06-03 |
2019-03-29 |
Фармасайкликс, Инк. |
Применение ингибиторов тирозинкиназы брутона (btk)
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
CN106905311A
(zh)
|
2010-08-27 |
2017-06-30 |
钙医学公司 |
调节细胞内钙的化合物
|
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
AU2011327824B2
(en)
*
|
2010-11-08 |
2016-06-02 |
Cadila Pharmaceuticals Limited |
Pharmaceutical composition of taxoids
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
CA2826452C
(en)
*
|
2011-02-04 |
2016-11-22 |
Biocopea Limited |
Compositions and methods for treating cardiovascular diseases
|
|
US9561243B2
(en)
|
2011-03-15 |
2017-02-07 |
Phosphagenics Limited |
Composition comprising non-neutralised tocol phosphate and a vitamin A compound
|
|
JP2014534228A
(ja)
|
2011-11-02 |
2014-12-18 |
シンタ ファーマシューティカルズ コーポレーション |
白金含有剤とｈｓｐ９０阻害剤の組合せ療法
|
|
JP2014532712A
(ja)
|
2011-11-02 |
2014-12-08 |
シンタ ファーマシューティカルズ コーポレーション |
トポイソメラーゼｉ阻害剤とｈｓｐ９０阻害剤の組合せを使用する癌療法
|
|
US9717678B2
(en)
*
|
2011-11-06 |
2017-08-01 |
Murty Pharmaceuticals, Inc. |
Delivery systems for improving oral bioavailability of Fenobam, its hydrates, and salts
|
|
AU2012339679A1
(en)
|
2011-11-14 |
2014-06-12 |
Synta Pharmaceuticals Corp. |
Combination therapy of Hsp90 inhibitors with BRAF inhibitors
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
EP2811847B1
(en)
|
2012-02-10 |
2017-12-13 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
|
US20130226550A1
(en)
*
|
2012-02-23 |
2013-08-29 |
Hassan Benameur |
Systems and methods for modeling compound formulations
|
|
WO2013177226A1
(en)
|
2012-05-21 |
2013-11-28 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
|
AR091857A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
|
AR091858A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
MX2015006681A
(es)
|
2012-11-29 |
2016-04-06 |
Insmed Inc |
Formulaciones de vancomicina estabilizadas.
|
|
TWI614017B
(zh)
*
|
2012-12-21 |
2018-02-11 |
財團法人國家衛生研究院 |
包含中孔洞矽奈米粒子之組成物的用途
|
|
JP6122646B2
(ja)
*
|
2013-01-23 |
2017-04-26 |
昭和電工株式会社 |
皮膚外用剤
|
|
EP2968475A2
(en)
|
2013-03-14 |
2016-01-20 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of acute respiratory distress syndrome
|
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
|
WO2014165672A1
(en)
*
|
2013-04-06 |
2014-10-09 |
Igdrasol, Inc. |
Nanoparticle therapeutic agents, their formulations, and methods of their use
|
|
US10299492B2
(en)
*
|
2013-06-20 |
2019-05-28 |
James John YIANNIOS |
Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same
|
|
US11044923B2
(en)
|
2013-06-20 |
2021-06-29 |
Vitasome Labs, Inc. |
Gummies containing formulations with enhanced delivery matrix, and methods of making same
|
|
US9585417B2
(en)
*
|
2013-06-20 |
2017-03-07 |
Vitasome Labs, Inc. |
Dietary supplement compositions with enhanced delivery matrix, and methods of making the same
|
|
US12256756B2
(en)
|
2013-06-20 |
2025-03-25 |
Vitasome Labs LLC. |
Gummies containing formulations with enhanced delivery matrix, and methods of making same
|
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
|
US9896403B2
(en)
*
|
2014-08-22 |
2018-02-20 |
Ironstone Separations, Inc. |
Solubilization of pterostilbene and resveratrol in aqueous beverages
|
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
ES2755941T3
(es)
|
2014-05-15 |
2020-04-24 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
|
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
MY182652A
(en)
*
|
2014-11-25 |
2021-01-27 |
Kl Kepong Oleomas Sdn Bhd |
Formulation for effective tocotrienol delivery
|
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
|
CA2977521C
(en)
|
2015-02-27 |
2024-03-19 |
Curtana Pharmaceuticals, Inc. |
1-(aryl)-3-(heteroaryl) urea compounds and their use as olig2 inhibitors
|
|
AU2016225026A1
(en)
|
2015-02-27 |
2017-09-07 |
Canopy Growth Corporation |
Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
|
|
US20180098936A1
(en)
*
|
2015-03-23 |
2018-04-12 |
President And Fellows Of Harvard College |
Methods and compositions for injecting high concentration and/or high viscosity active agent solutions
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
ES2836805T3
(es)
|
2015-08-03 |
2021-06-28 |
Tolmar International Ltd |
Sistema de administración de polímeros líquidos para la administración extendida de fármacos
|
|
CN108135904A
(zh)
|
2015-08-31 |
2018-06-08 |
药品循环有限责任公司 |
用于治疗多发性骨髓瘤的btk抑制剂组合
|
|
TWI752750B
(zh)
|
2015-09-30 |
2022-01-11 |
香港商慧源香港創新有限公司 |
口服紫杉烷組合物及方法
|
|
US9637514B1
(en)
|
2015-10-26 |
2017-05-02 |
MAX BioPharma, Inc. |
Oxysterols and hedgehog signaling
|
|
WO2017074957A1
(en)
|
2015-10-26 |
2017-05-04 |
MAX BioPharma, Inc. |
Oxysterols and hedgehog signaling
|
|
CN108601732A
(zh)
*
|
2015-12-09 |
2018-09-28 |
磷肌酸有限公司 |
药物制剂
|
|
US20170196802A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Abon Pharmaceuticals, Llc |
Long Acting Injectable Formulations
|
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
WO2017176652A2
(en)
|
2016-04-04 |
2017-10-12 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using trapidil
|
|
WO2017197240A1
(en)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
|
JP2019516773A
(ja)
|
2016-05-25 |
2019-06-20 |
コンセントリック アナルジジックス，インク． |
改善された局所麻酔のための局所麻酔薬及び血管収縮薬と組み合わせたフェノールｔｒｐｖ１アゴニストのプロドラッグ
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
BR112019003973A2
(pt)
|
2016-08-26 |
2019-10-08 |
Curtana Pharmaceuticals Inc |
inibição de atividade olig2
|
|
US10568865B2
(en)
*
|
2016-08-29 |
2020-02-25 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
US12485129B2
(en)
|
2016-08-29 |
2025-12-02 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
KR102487144B1
(ko)
|
2016-11-21 |
2023-01-12 |
에이리온 테라퓨틱스, 인코포레이티드 |
큰 물질의 경피 전달
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
IL267006B2
(en)
|
2016-12-21 |
2024-11-01 |
Phosphagenics Ltd |
Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
|
|
EP3565538A4
(en)
|
2017-01-08 |
2020-10-28 |
RESQ Pharma Inc. |
PROCESSES FOR REDUCING LESIONS ASSOCIATED WITH PEROPERATIVE HYPOTENSION
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
WO2019090205A1
(en)
|
2017-11-06 |
2019-05-09 |
Snap Bio, Inc. |
Pim kinase inhibitor compositions, methods, and uses thereof
|
|
WO2019094772A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of Michigan |
Ash1l degraders and methods of treatment therewith
|
|
CN112040947A
(zh)
|
2017-12-07 |
2020-12-04 |
密歇根大学董事会 |
Nsd家族抑制剂及用其进行治疗的方法
|
|
EP3508562A1
(en)
*
|
2018-01-05 |
2019-07-10 |
Castrol Limited |
Micellar emulsions
|
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
MA52251A
(fr)
|
2018-04-30 |
2021-02-17 |
Cedars Sinai Medical Center |
Procédés et systèmes de sélection et de traitement de patients souffrant de maladies inflammatoires
|
|
WO2019227041A1
(en)
*
|
2018-05-25 |
2019-11-28 |
Resq Pharma, Inc. |
Lipid emulsions and uses thereof
|
|
CA3102777A1
(en)
|
2018-06-07 |
2019-12-12 |
The Regents Of The University Of Michigan |
Prc1 inhibitors and methods of treatment therewith
|
|
US12264368B2
(en)
|
2018-07-06 |
2025-04-01 |
Cedars-Sinai Medical Center |
Methods of treating refractory inflammatory disease using transcriptomic and genetic risk signatures
|
|
CA3107214A1
(en)
|
2018-07-20 |
2020-01-23 |
Lipocine Inc. |
Liver disease
|
|
TW202019887A
(zh)
|
2018-07-27 |
2020-06-01 |
美商同心止痛劑股份有限公司 |
酚系trpv1促效劑之聚乙二醇化前藥
|
|
US12246042B2
(en)
|
2018-08-29 |
2025-03-11 |
Myos Corp. |
Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals
|
|
CA3113226A1
(en)
|
2018-09-20 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US20220040201A1
(en)
*
|
2018-09-25 |
2022-02-10 |
Tolmar International, Ltd. |
Liquid polymer delivery system for extended administration of drugs
|
|
US12251405B2
(en)
|
2018-10-03 |
2025-03-18 |
Myos Corp. |
Spray dried follistatin product
|
|
WO2020096660A1
(en)
|
2018-11-06 |
2020-05-14 |
Myos Rens Technology, Inc. |
Methods and compositions for improving skeletal muscle protein fractional synthetic rate
|
|
WO2020135920A1
(en)
*
|
2018-12-28 |
2020-07-02 |
Université Libre de Bruxelles |
Kit for inhaled chemotherapy, and treatment of lung cancer with said kit
|
|
MX2021007925A
(es)
|
2018-12-31 |
2021-10-26 |
Biomea Fusion Llc |
Inhibidores irreversibles de la interaccion menina-mll.
|
|
US11833186B2
(en)
|
2019-02-01 |
2023-12-05 |
Myos Corp. |
Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
|
|
IL286434B1
(en)
|
2019-03-15 |
2025-10-01 |
Unicycive Therapeutics Inc |
Nicotinell derivatives
|
|
WO2020232125A1
(en)
|
2019-05-14 |
2020-11-19 |
Prometheus Biosciences, Inc. |
Tl1a patient selection methods, systems, and devices
|
|
CN114269360A
(zh)
|
2019-06-21 |
2022-04-01 |
恩特莱科索生物治疗公司 |
用于治疗递送的平台、组合物和方法
|
|
WO2021195258A1
(en)
*
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor, formulations, and uses thereof
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
EP4162076A4
(en)
|
2020-06-03 |
2024-10-02 |
Cedars-Sinai Medical Center |
TREATMENTS FOR A SUBPOPULATION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
|
EP4161492A1
(en)
*
|
2020-06-05 |
2023-04-12 |
University Of Cyprus |
Therapeutic nanocarrier system and methods of use
|
|
CN116113406B
(zh)
|
2020-07-10 |
2025-08-29 |
密歇根大学董事会 |
Gas41抑制剂及其使用方法
|
|
JP2023543352A
(ja)
*
|
2020-09-22 |
2023-10-13 |
マイクロナイゼーション テクノロジーズ アンド セラピューティクス グループ エルエルシー |
噴霧器および噴霧化された抗ウイルス薬
|
|
EP4263542A1
(en)
|
2020-12-16 |
2023-10-25 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
|
CA3228627A1
(en)
|
2021-08-11 |
2023-02-16 |
Thomas Butler |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
|
US20240409558A1
(en)
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
AU2022357226A1
(en)
|
2021-09-28 |
2024-05-02 |
Blacksmith Medicines, Inc. |
Lpxc inhibitors and uses thereof
|
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
|
IL313670A
(en)
|
2021-12-30 |
2024-08-01 |
Biomea Fusion Inc |
Pyrazine compounds as inhibitors of FLT3
|
|
US20250353854A1
(en)
|
2022-06-03 |
2025-11-20 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
KR20250091267A
(ko)
|
2022-10-19 |
2025-06-20 |
마이오스 코퍼레이션 |
근육 생성 화합물
|
|
US20250002458A1
(en)
|
2023-05-24 |
2025-01-02 |
Unicycive Therapeutics Inc. |
Salt forms of nicorandil derivative
|
|
WO2024249950A1
(en)
|
2023-06-02 |
2024-12-05 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
US20250145571A1
(en)
|
2023-09-26 |
2025-05-08 |
Unicycive Therapeutics, Inc. |
Amino acid prodrugs of nicorandil
|
|
WO2025194102A1
(en)
|
2024-03-15 |
2025-09-18 |
Unicycive Therapeutics, Inc. |
Pyridine modified nicorandil derivatives
|
|
US20250304572A1
(en)
|
2024-03-29 |
2025-10-02 |
Biomea Fusion, Inc. |
Heterocyclic glp-1r agonists
|